Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Upadacitinib proves long-term efficacy in RA

Upadacitinib proves long-term efficacy in RA

17 Jul 2024 bởiStephen Padilla

Upadacitinib remains effective through 5 years in patients with rheumatoid arthritis (RA) who have inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), with no new safety signals, as shown by the results of the phase III long-term extension (LTE) of SELECT-NEXT.

17 Jul 2024
Reduced kidney function after stroke ups risk of recurrence, dementia

Reduced kidney function after stroke ups risk of recurrence, dementia

17 Jul 2024

Patients with declining kidney function following a cerebrovascular event are at increased risk of major adverse cardiovascular events (MACE), dementia, and mortality at 2 years, according to a study. However, a higher risk of death is also noted for those with a large increase in kidney function.

17 Jul 2024